Abnormal expression of CDKN1C plays a role in breast cancer (Qiu et al., 2018), gastric cancer (Sun et al., 2017), glioma (Zhang et al., 2015) and other cancers. This evidence concerns the gene CDKN1C and breast carcinoma.